e-Drug3D

2056

MITAPIVAT

INN
MITAPIVAT

cas 1260075-17-9

CLASS

METABOLISM
TREATMENT OF HEMOLYTIC ANEMIA WITH PYRUVATE KINASE (PK) DEFICIENCY
PYRUVATE KINASE ACTIVATOR
BINDS THE PROTEIN TETRAMER

ROUTE (list)

ORAL

ATC code

B06AX04

PK parameters

F 73 PERCENT
Tmax 0.75 HOUR
VD 42.5 LITER
Cl 14.4 LITER / HOUR
PPB 97.7 PERCENT
t1/2 4 HOUR

Solubility

SLIGHTLY SOLUBLE IN WATER

Target

TARGET PYRUVATE KINASE

PDB
8XFD (CRYSTAL STRUCTURE OF PYRUVATE KINASE TETRAMER IN COMPLEX WITH ALLOSTERIC ACTIVATOR, MITAPIVAT (MTPV, AG-348))

Download experimental 3D coordinates of WV2 with added hydrogens

Pyruvate kinase PKLR UNIPROT P30613

Download SDF file

8-Quinolinesulfonamide, N-[4-[[4-(cyclopropylmethyl)-1-piperazinyl]carbonyl]phenyl]- (ACI)

Formula:
C24H26N4O3S

Calculated chemical properties:

MW 450.56
NB_atoms 32
XLogP 3.20
PSA 78.598
NB_HD 1
NB_HA 7
fsp3 0.33
Lipinski(0=no;1=yes) 1

FDA
NDA 216196 (label) INN (MITAPIVAT SULFATE) PYRUKYND (AGIOS PHARMS INC) APPROVAL= AP YEAR= 2022 NEWMOLECULARENTITY